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To investigate the time course of restenosis, serial treadmill
exercise testing was performed in the absence of medical
therapy by 31 patients with single vessel coronary disease
who underwent successful angioplasty. Exercise tests were
performed before angioplasty and at 3 days and 1, 3 and 6
months after angioplasty; if the test was positive, it was
repeated after administration of 10 mg of intravenous
verapamil. At arteriography 6 months after coronary an-
gioplasty, 17 patients (group 1) showed no restenosis but 14
patients (group 2) did. Before angioplasty all 31 patients
had a positive exercise test with ST segment depression
<::lmm.
At 3 days after angioplasty, three patients in group 1
had a positive exercise test compared with 11 patients in
group 2(p =0.08). At 1, 3and 6 months, 1 patient in group
1 had a positive exercise test compared with 14 patients in
group 2 (p < 0.01).
The heart rate-blood pressure product (beats/min;mm
Hg) calculated at 1 mm ST segment depression, or at peak
exercise if the test was negative, was used as an index of the
Restenosis remains one of the major limitations of the use of
coronary angioplasty as a treatment for angina pectoris (1).
The reported incidence rate (2-4) at 6 months after angio-
plasty has varied from 13% to 47%. Restenosis is usually
associated with a positive exercise test for myocardial isch-
emia and accompanied by angina. Although it is already
present at 3 months after angioplasty in most patients in
whom restenosis occurs (5), its time course is poorly known.
To this end we performed serial treadmill exercise testing
From the Cardiovascular Research Unit, Royal Postgraduate Medical
School, Hammersmith Hospital, London, England.
Manuscript received May 12, 1989; revised manuscript received Septem-
ber 11,1989, accepted September 26, 1989.
Mdress for reprints: Hassan EI-Tamimi, MD, The Cardiovascular Re-
search Unit, Royal Postgraduate Medical School, Hammersmith Hospital,
Ducane Road, London W12, England.
©1990 by the American College of Cardiology
ischemic threshold. In group 1 (no restenosis) the ischemic
threshold increased progr~ively from 14,840 ± 1,075
(mean value ± SEM) before angioplasty to 21,210 ± 1,049
at 3 days and to 25,140 ± 1,177 (p < 0.001) at 6 months. In
group 2 (restenosis) the ischemic threshold. increased from
16,270 ± 828 before angioplasty to 20,400 ± 984 (p <
0.0004) at 3 days but decreased to 16,090 ± 1,298 (p <
0.006) at 6 months. The dift'erence in ischemic threshold
between the two groups waS significant (p < 0.05) from 1
month onward. In group 2 patients the increase in ischemic
threshold after verapamil was greater at 3 and 6 months
after than before angioplasty (p < 0.01).
The early high incidence of Ii positive exercise test
indicates that the process of resttmosis begins at least within
1 month of angioplasty and perhaps as early as 3 days.
Furthermore, the dynamic component of the stenosis after
angioplasty is greater than that of the original stenosis, as
suggested by the response to verapamil.
(J Am CoO CardioI1990;15:259-64)
without therapy and follow-up coronary arteriography in 31
patients with single vessel disease before and after success-
ful angioplasty. In seven patients the dynamic component of
restenosis was assessed by repeating each exercise test after
administration of the calCium channel blocker verapamil.
Methods
Study patients. Thirty-one consecutive patients with sin-
gle vessel disease underwent elective percutaneous trans-
luminal coronary angioplasty for chronic stable angina pec-
toris and follow-up coronary arteriography 6 months later.
There were 28 men and 3 women aged 36 to 73 years (mean
54) and all had a positive exercise test for myocardial
ischemia before angioplasty. Seven patients had a previous
(>6 months) Q wave myocardial infarction (five inferior, two
anterior) in the region of the diseased coronary artery. Even
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though seven patients had Q waves, there was enough
preservation of R waves in these leads to allow analysis of
ST segment changes for myocardial ischemia. No patient
had evidence of left ventricular hypertrophy or conduction
defects on the electrocardiogram (ECG) that could have
interfered with the interpretation of ST segment changes,
and no patient was taking digitalis.
Study protocol. The protocol was approved by the Ham-
mersmith Hospital Research Ethics Committee and all pa-
tients gave full informed consent for the study. All patients
underwent a treadmill exercise ECG during the week before
angioplasty. All antianginal therapy was discontinued before
the test (beta-adrenergic blocking agents were stopped for
72 h, calcium channel blockers and oral nitrates for 24 h). All
patients were taking aspirin, 75 mg daily, but none received
dipyridamole. Patients were free to use sublingual nitroglyc-
erin as required, but no exercise test was performed within
2 h of its administration. In seven patients the test was
repeated 1 h later after the slow intravenous administration
of verapamil, 10 mg.
Coronary angioplasty was performed by a standard tech-
nique using the femoral approach. Heparin, 10,000 IV, was
administered at the beginning of the procedure and main-
tained as an intravenous infusion for 12 h after the proce-
dure. During angioplasty, an intravenous isosorbide dinitrate
infusion was maintained with supplementary bolus injections
of intracoronary isosorbide dinitrate as required and contin-
ued for 24 h after angioplasty. Aspirin, 75 mg/day, was
continued during and for 6 months after the angioplasty.
Diltiazem, 180 mg/day, was started 24 h after the procedure
and also continued for 6 months.
A repeat exercise test without therapy was performed at
3 days and at 1, 3 and 6 months after angioplasty. If the test
was positive it was repeated 1 h later, after the slow
intravenous administration of 10 mg verapamil. In all pa-
tients, follow-up coronary arteriography was performed ap-
proximately 6 months after angioplasty with use of the same
radiographic projections as those obtained during the proce-
dure.
Exercise testing. Exercise testing using the modified
Bruce protocol was performed on a computerized treadmill
system (Compustress Inc.). Twelve lead ECG recordings
and (cuft) blood pressure measurements were obtained at
rest, at the end of each stage during exercise, at the point of
1 mm ST segment depression, at peak exercise and at 3 and
6 min into the recovery period. Three ECG leads were
monitored continuously before and during exercise and for 6
min into recovery. All tests were performed at the same time
of day for each patient. A positive exercise test diagnostic of
myocardial ischemia was defined as horizontal or downslop-
ing ST segment depression;;:: 1mm (0.1 mV) measured 60 ms
after the J poirit with respect to the value at rest. The
exercise test was stopped in the event of chest pain of
moderate severity, ST segment depression ;;::2 mm or inabil-
ity of the patient to exercise further.
For all exercise tests the heart rate-blood pressure prod-
uct (beatslmin-mm Hg) was calculated at 1 mm ST segment
depression, or at peak exercise when the exercise test was
negative, and its value was used as an index of the ischemic
threshold. The reason for stopping the test was noted.
Cardiac catheterization. Selective right and left coronary
arteriography was performed by the Judkins technique.
Each vessel was filmed in multiple projections. The coronary
artery luminal diameter at the site of the original stenosis
was measured from end-diastolic frames of identical projec-
tions of the arteriograms recorded before and after angio-
plasty and at 6 months using an automated edge contour
detection analysis system (Computerised Angiographic
Analysis System [CAAS] Version 2V2; Pie Data Medical)
(6). High resolution video-converted digital images of the
film frames were automatically corrected for radiographic
pincushion distortion, and the known size of the stem of the
coronary catheters was used for calibration. The results
were expressed as percent diameter stenosis compared with
the adjacent normal segment. Restenosis was defined, in
accordance with the definition of the National Heart, Lung,
and Blood Institute (2), as a loss of ;;::50% of the initial gain
in luminal diameter.
Statistical analysis. Statistical analysis was performed by
using analysis of variance or the two-tailed Student's t test
for paired data as appropriate. The results are expressed as
mean values ± SEM. A value of p < 0.05 is considered
significant; p values were adjusted for the multiple test
situation by the use of Bonferroni inequality.
Results
Changes in coronary stenosis (Fig. 1). Two groups were
defined on the basis of the 6 month follow-up arteriogram.
Group 1 consisted of 17 patients without restenosis and
group 2consisted of 14 patients (45.2%) with restenosis. The
two groups were similar with respect to the severity of
stenosis before and immediately after angioplasty. The ste-
nosis severity was 67.9 ± 1.5% and 70.0 ± 2.4% before
angioplasty, 31.4 ± 3.5% and 29.8 ± 2.9% immediately after
angioplasty and 27.5 ± 4.0% and 62.9 ± 3.5% at 6 months in
groups 1 and 2, respectively.
Exercise tolerance and ischemic threshold. Before angio-
plasty (Fig. 2). All exercise tests were positive for myocar-
dial ischemia. There was no significant difference between
the two groups in the ischemic threshold as assessed from
the heart rate-blood pressure product (beats/min·mm Hg); it
was 14,840 ± 1,075 in group 1 and 16,270 ± 828 in group 2.
In group 1 (no restenosis) the exercise test was stopped
because of chest pain in nine patients and ST segment
depression in five patients. In group 2 (with restenosis), the
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exercise test was negative in 3patients who stopped because
of fatigue; it was positive in the remaining 11 patients, of
whom 4 stopped exercise because of chest pain, 4 because of
ST segment depression and the remaining 3 because of
fatigue. The predictive value of a positive test for restenosis
was 79%; that of a negative test was 82%. Both groups
showed a significant increase in the ischemic threshold
compared with that before angioplasty; it increased from
14,840 ± 1,075 to 21,210 ± 1,049 (p < 0.0001) in group 1and
from 16,270 ± 828 to 20,400 ± 984 (p < 0.0004) in group 2.
The difference between the two groups was not significant
(Fig. 2).
One month after angioplasty. In group 1all exercise tests
were negative, and all patients stopped with fatigue. In group
2, 1 patient had a negative exercise test and stopped with
fatigue; the test was positive in 13 patients, of whom 5
stopped with chest pain, 5 with ST segment depression and
3 with fatigue. The predictive value of a positive test for
restenosis was 100% and that of a negative test was 94%.
Group I showed a further increase in ischeInic threshold
compared with that at 3 days; the threshold increased from
21,210 ± 1,049 to 23,300 ± 1,077 (p < 0.02), but it remained
almost unchanged in group 2, from 20,400 ± 984 to 20,870 ±
830 (p = NS). The difference between the two groups was
significant (p < 0.05) at this stage (Fig. 2).
Three months after angioplasty. In group 1 all exercise
tests were negative and all patients stopped with fatigue. In
group 2 the exercise test was negative in 1 patient, who
stopped with fatigue; it was positive in 13 patients, of whom
6stopped with chest pain, 6 with ST segment depression and
1 with fatigue. The predictive value of a positive test for
restenosis was 100% and that of a negative test was 94%. In
group 1, the ischemic threshold increased from 23,300 ±
1,077 at 1 month to 24,480 ± 965 at 3 months (p = NS), but
it decreased in group 2 from 20,870 ± 830 at 1 month to
18,800 ± 1,636 (p = NS). The difference between the two
groups was significant (p < 0.004) (Fig. 2).
Six months after angioplasty. In group 1, all exercise
tests were negative and all patients stopped with fatigue. In
group 2, the exercise test was negative and stopped with
fatigue in 1patient, but was positive in 13 patients: 5 stopped
with chest pain, 7 with ST segment depression and 1 with
fatigue. The predictive value of a positive test for restenosis
was 100% and of a negative test it was 94%. In group 1, the
ischemic threshold increased from 24,480 ± %5 at 3 months
to 25,140 ± 1,177 at 6 months (p = NS). However, in group
2 it decreased further from 18,800 ± 1,636 at 3 months to
16,090 ± 1,298 (p < 0.0006). The difference between the two
groups was significant (p < 0.0001) (Fig. 2).
Initial response to coronary angioplasty. When compared
with the value before angioplasty, ischemic threshold im-
proved (by ;:::2,000 beats/min'mm Hg) in 23 of the 31 patients
at 3 days after angioplasty, whereas it did not improve
significantly in the other 8 patients. However, these latter
Restenosis
(14)
-------~
Non-reslenosis
(17)
* pd}.OOI vsPfe
** pd}.006 vs 3m
• pd}.Ot vs 3d
20%
0% -11---.."..-----..,1-----.."
Pre Immediate 6m
PTCA Post PTCA
30%
60%
40%
50%
70%
80%
12.000
20
<II
15(;) 15~!!
llGlE~
10~'[
5
0
~~ 22.000
! 17.000
Q.
a:
27.000
Figure 2. Mean heart rate-blood pressure product (RPP) of both
groups and the corresponding number of positive exercise tests at
each time interval. The group with no restenosis (group I) showed a
continuous improvement of mean heart rate-blood pressure product
up to 6 months after angioplasty and all tests become negative from
1 month onward. The group with restenosis (group 2) showed an
initial improvement of mean heart rate-blood pressure product at 3
days after angioplasty but it decreased from 3 months onward and
most tests were positive from 1 month onward. Hatched bars =
nonrestenosis; open bars = restenosis; Pre = before angioplasty.
exercise test was stopped in 12 patients because of chest
pain and in 2 patients because of ST segment depression.
Three days after angioplasty. In group 1the exercise test
was negative, and 14 patients stopped exercise because of
fatigue; the remaining 3 patients had a positive test and
stopped because of ST segment depression. In group 2, the
Figure 1. Mean percent diameter stenosis of both group 1 (non-
restenosis) and group 2 (restenosis) before angioplasty (PTCA) and
immediately and 6 months after angioplasty. The two groups were
similar with respect to the severity of stenosis before and immedi-
ately after angioplasty.
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Figure 3. Mean heart rate-blood pressure product (RPP) without
therapy (Rx) and after intravenous verapamil with the correspond-
ing number of positive exercise tests at each time interval. Vera-
pamil induced an improvement in mean heart rate-blood pressure
product at 3and 6 months after angioplasty, which waS significantly
higher than that before angioplasty (Pre). Hatched bars = without
therapy; open bars = on verapamil. .
patients had a significantly higher ischemic threshold before
angioplasty (19,688 ± 983) than did the 23 patients showing
improvement (14,026 ± 1,082). Furthermore, six (75%) of
these eight patients with a high ischemic threshold before
angioplasty subsequently developed restenosis.
Effect of verapamil on exercise tolerance. In seven of the
group 2 patients (with restenosis) who had a positive exer-
cise test without therapy before coronary ~ngioplasty and at
1, 3 and 6 months after angioplasty (six of whom had a
positive test at 3 days), the exercise test 'was repeate<i 1 h
later, after the intravenous administration of 10 mg vera-
pamil. After verapamil, one test became negative before
angioplasty, four tests became negative at 3 days, three at 1
month, three at 3 months and two at 6 months. After
verapamil the ischemic threshold increased by 2,168 ± 731
(p < 0.02) before angioplasty, by 1,294 ± 1,876 (p = NS) at
3 days, by 4,039 ± 764 (p < 0.000 at 1 month, by 4,931 ±
1,334 (p < 0.01) at 3 months and by 4,946 ± 1,276 (p < 0.008)
at 6 moIiths (Fig. 3). The increase in ischemic threshold
induced by verapamil was significantly greater at 3 months
and 6 months compared with that before angioplasty (p <
0.01).
Discussion
Predictive value of a positive exercise test 3 days after
angioplasty. This study shows that the predictive value of a
positive exercise test with respect to restenosis is high from
3days after angioplasty onward. Even at 3 days, 11 of the 14
patients who were later found to have developed restenosis
already had a positive exercise test, indicating that their
coronary flow reserve was already impaired. From I month
onward, 13 of the 14 patients who developed restenosis had
a positive exercise test. It is therefore quite clear that either
restenosis or the processes that lead or predispose to it are
already present within days of the procedure. Whether fixed
anatomic restenosis, enough to limit coronary flow reserve
and result in a positive exercise test, is already present at 3
days after angioplasty is not clear from this study, but
certainly the efficacy of the angioplasty in reducing the
stenosis was similar in both groups as evidenced by the
stenosis severity immediately after the balloon dilation.
Possible pathophysiologic mechanisms. It would be quite
reasonable to hypothesize that the early positive exercise
tests were due partly to a dynamic component such as
vasoconstriction (7,8) because the vessel wall damage asso-
ciated' with balloon angioplasty is likely to lead to platelet
adhesion and aggregation (9-12) and the local release of
vasoconstrictor substances (13,14). Furthermore, the local
migration of vascular smooth muscle cells into the intima
and their proliferation in response to platelet-derived growth
factor (9,15) would provide a mechanism for vasoconstric-
tion and also form part of the fibromuscular response to
balloon dilation that ultimately constitutes the anatomic
lesion in restenosis (16). A recent study by Fischel et a1. (7)
clearly demonstrated spontaneous coronary artery constric-
tion immediately after angioplasty, and persistence of this
tendency for several days could explain the occurrence of a
positive exercise test 3 days after angioplasty (as found in
our study) even if anatomic restenosis had not occurred to a
degree comparable with that of the preexisting stenosis.
Comparison with other studies. In our study a relatively
homogeneous group of patients was selected on the basis of
single ves~el disease and a positive exercise test before
angioplasty, with all exercise tests performed without ther-
apy. Therefore, precise comparison cannot be made with the
results of other studies. However, the results of our study
are consistent with those of Wijns et a1. (5), who found 74%
of exercise tests positive at 4 weeks after angioplasty in
those patients in whom restenosis ultimately occurred.
DePuey et a1. (17) studied patients before and after angio-
plasty with exercise-gated radionuclide ventriculography
and found that patients with abnormal findings as early as 4
days after angioplasty had a significantly higher restenosis
rate than those without such findings. In a study by Jain et al.
(18), evidence of impaired coronary flow reserve was found
48 h after angioplasty on the basis of dipyridamole-induced
regional defects in thallium-20I uptake and 71% of these
patients had developed restenosis after an average interval
duration of 21.7 months. However, in the group developing
restenosis the severity of stenosis immediately after angio-
plasty was greater than in the group without restenosis and
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thus significant fixed residual stenosis might have been
responsible for the impairment of coronary flow reserve, at
least in some of these patients.
Perhaps the definitive study on the anatomic aspect of
restenosis was reported recently by Nobuyoshi et al. (19).
The study involved serial follow-up coronary arteriography
in 229 patients subjected to angioplasty and found an actu-
arial restenosis rate of 43% at 3 months and of 52.5% at 1
year, although the restenosis rate at 1 month was only
12.7%. These findings suggest that the relatively high fre-
quency of positive exercise tests at 1 month in our study
could represent either a dynamic change in stenosis severity
occurring during exercise or an increase in resistance in the
smaller vessels. With regard to the latter hypothesis a
reduced coronary flow reserve immediately after angioplasty
was found by Wilson et al. (20) using the technique of
intracoronary Doppler flow velocity measurement and pa-
paverine-induced maximal vasodilation. In that study the
impairment of coronary flow reserve found in 17 of 31
patients was unrelated to the severity of the epicardial vessel
stenosis and had either resolved at an average of?.5 months
after angioplasty or persisted in association with restenosis
where it correlated significantly with the severity of resteno-
sis. The results of their study, however, require further
validation because the assessment of coronary flow reserve
by this technique did not take into account the basal level of
flow, which might have been elevated immediately after
angioplasty. Such further validation and confirmation of
these findings would suggest that a regional increase in small
vessel resistance might contribute to the early limitation of
coronary flow reserve.
Effect of verapamil. In our study, the magnitude of the
change in ischemic threshold induced by verapamil was
significantly greater at 3 and 6 months after angioplasty
compared with that observed before angioplasty. This
finding is of interest because the effect of verapamil on
ischemic threshold has been used in previous studies to
assess the magnitude of the dynamic component of coronary
stenosis. Intravenous calcium blocking agents have been
shown to slightly dilate both the normal and stenotic seg-
ments of coronary arteries (21) and to prevent exercise-
induced vasoconstriction (22) and coronary vasospasm (23).
The results of our study suggest that the restenotic coronary
artery might constrict more during exercise than would the
atherosclerotic artery before angioplasty. This finding would
be consistent with the cellular nature of the restenotic lesion,
whose cellular component contains mainly smooth muscle
cells. This restenotic lesion, therefore, might induce coro-
nary obstruction not only by its physical presence but also
by an enhanced constrictor response to exercise.
Clinical implication. These results indicate the value of
ECG exercise stress testing in the early identification of
those patients with single vessel disease who are in the
process of developing restenosis. Routine follow-up coro-
nary arteriography would appear to be of little value in the
event of a persistently negative exercise stress test. Our
results also indicate that little value, in terms of exercise
tolerance, is obtained from angioplasty in patients whose
ischemic threshold (blood pressure-heart rate product) is
already high before angioplasty. In fact, a high proportion of
patients with restenosis were found in this group and in some
of them the ischemic threshold had fallen at 3 days after
angioplasty to a level below that observed before angio-
plasty. In these patients with a high ischemic threshold and
good effort tolerance before angioplasty the severity of
coronary stenosis was very similar to that of the other
patients, therefore, the coronary arteriogram should not be
used in isolation when selecting patients who are likely to
benefit from angioplasty.
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